The Cannigma

OCTOBER 25, 2021

In 2018 Canada legalized recreational cannabis use, becoming the first G7 country to do so and only the second country after Uruguay, which legalized cannabis in 2013. Canadian law allows people to receive medical cannabis for any condition or symptoms approved by their personal healthcare practitioner.

Legalization 106

Legalization Packaging Edibles Retail 106

Cannabis Law Report

MARCH 29, 2020

o Medical conditions: A panel of doctors must be present at the time of any product research to ensure no adverse effects lessen or damage the health of participants. Canada’s largest syndicated study of cannabis consumers reveals that price remains a top barrier to legal cannabis consumption. .

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

OCTOBER 24, 2021

On June 7, 2013, the federal government implemented the Marijuana for Medical Purposes Regulations (MMPR) 1. Cannabis flower still held as the most common form of consumption but vaping, edibles, and topicals picked up in popularity. The Government of Canada Consumer Survey asked respondents about their methods of consumption.

Strains 52

Strains Edibles Extraction Vaping 52

Cannabis Law Report

JANUARY 29, 2019

Cannabis should be classified as a medicinal product, she said, and therefore all active ingredients msu be displayed on the packaging. . “We We must under no circumstances trivialise or propagate consumption,” she told local media.

Legalization 40

Legalization Medicine Recreational Banking 40

Cannabis Law Report

MAY 13, 2019

These days, the industry in Nevada faces some steep challenges, including the lack of banking services and some serious questions — raised in numerous lawsuits — that the state’s process for distributing conditional licenses was unfair. Marijuana used to be heroin in Nevada back in 2013. Photo by Michelle Rindels. What didn’t make it.

Legislation 58

Legislation Banking Consumption Conditions 58

Cannabis Law Report

OCTOBER 29, 2019

Dr. Wakshlag and ElleVet are currently conducting additional clinical trials to demonstrate the efficacy of ElleVet hemp CBD/CBDA in other important conditions. Pharmacokinetic variables were estimated by means of non-compartmental analysis, utilizing a pharmacokinetic software package (PK Solution, version 2.0, Wakshlag, DVM, Ph.D.,

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JULY 12, 2019

More research is needed to determine proper ratios for specific conditions, as well as genetic testing developed to determine appropriate course of treatment. Moreover, since CBD can never be fully isolated, the packaging of CBD medicines should warn about the presence of THC. 2013 Sep;36(9):2530-5. References. Diabetes Care.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73